In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2

In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2

In December 2019, a new severe acute respiratory syndrome coronavirus (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19), emerged in Wuhan, China. Despite containment measures, SARS-CoV-2 spread in Asia, Southern Europe, then in America and currently in Africa. Identifying effective antiviral...

Full description

Bibliographic Details
Main Authors: Mathieu Gendrot, Julien Andreani, Priscilla Jardot, Sébastien Hutter, Océane Delandre, Manon Boxberger, Joel Mosnier, Marion Le Bideau, Isabelle Duflot, Isabelle Fonta, Clara Rolland, Hervé Bogreau, Bernard La Scola, Bruno Pradines
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Molecules
Subjects:
COVID-19
SARS-CoV-2
doxycycline
treatment
prophylaxis
antiviral
Online Access:https://www.mdpi.com/1420-3049/25/21/5064

Internet

https://www.mdpi.com/1420-3049/25/21/5064

Similar Items